The effects of raloxifene hydrochloride on ocular hemodynamics and visual function

Brent Siesky, Akon Harris, Nisha Kheradiya, Rita Ehrlich, Carissa Klaas, Boaris Kaplan, Yara Catoira, Lynne McCranor, Carlos Rospigliosi, Mira Harris

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To assess the comprehensive effects of raloxifene hydrochloride on retinal, choroidal and retrobulbar hemodynamics and on visual function in post-menopausal women. Design: Twenty-four post-menopausal women (age 55 ± 3.8 years) were recruited for this cross-sectional study: 12 received placebo and 12 received raloxifene hydrochloride 60 mg once a day for 3 months. Baseline measurements of both groups included heart rate (HR), blood pressure (BP), visual acuity, contrast sensitivity and intraocular pressure (IOP) for both eyes. A comprehensive ocular blood flow (OBF) assessment was obtained for each patient in a randomly chosen study eye. Retinal blood flow data was obtained using confocal scanning laser Doppler flowmetry [Heidelberg Retinal Flowmeter (HRF)]. Color Doppler imaging (CDI) was used to assess retrobulbar hemodynamics in the ophthalmic, central retinal, short nasal and temporal posterior ciliary arteries. Baseline vision and hemodynamics in post-menopausal subjects were compared using paired Student's t tests, and the percentage change in baseline versus 3-month parameters was analyzed. Results: There were no statistically significant differences between 3 months of raloxifene therapy and placebo in terms of age, HR, arterial or mean BP, visual acuity, contrast sensitivity, IOP or retinal or retrobulbar blood flow. Conclusion: Raloxifene therapy at 60 mg/day had no clinically significant impact on BP, IOP or OBF in post-menopausal women.

Original languageEnglish (US)
Pages (from-to)225-230
Number of pages6
JournalInternational Ophthalmology
Volume29
Issue number4
DOIs
StatePublished - Jan 1 2009

Fingerprint

Hemodynamics
Intraocular Pressure
Contrast Sensitivity
Blood Pressure
Visual Acuity
Heart Rate
Ciliary Arteries
Placebos
Flowmeters
Laser-Doppler Flowmetry
Nose
Color
Cross-Sectional Studies
Raloxifene Hydrochloride
Students
Therapeutics

Keywords

  • Blood flow
  • Hormone
  • Raloxifene
  • Vision

ASJC Scopus subject areas

  • Ophthalmology

Cite this

The effects of raloxifene hydrochloride on ocular hemodynamics and visual function. / Siesky, Brent; Harris, Akon; Kheradiya, Nisha; Ehrlich, Rita; Klaas, Carissa; Kaplan, Boaris; Catoira, Yara; McCranor, Lynne; Rospigliosi, Carlos; Harris, Mira.

In: International Ophthalmology, Vol. 29, No. 4, 01.01.2009, p. 225-230.

Research output: Contribution to journalArticle

Siesky, B, Harris, A, Kheradiya, N, Ehrlich, R, Klaas, C, Kaplan, B, Catoira, Y, McCranor, L, Rospigliosi, C & Harris, M 2009, 'The effects of raloxifene hydrochloride on ocular hemodynamics and visual function', International Ophthalmology, vol. 29, no. 4, pp. 225-230. https://doi.org/10.1007/s10792-008-9224-4
Siesky, Brent ; Harris, Akon ; Kheradiya, Nisha ; Ehrlich, Rita ; Klaas, Carissa ; Kaplan, Boaris ; Catoira, Yara ; McCranor, Lynne ; Rospigliosi, Carlos ; Harris, Mira. / The effects of raloxifene hydrochloride on ocular hemodynamics and visual function. In: International Ophthalmology. 2009 ; Vol. 29, No. 4. pp. 225-230.
@article{6173257f71b54c2f93980a517dde5bbd,
title = "The effects of raloxifene hydrochloride on ocular hemodynamics and visual function",
abstract = "Objective: To assess the comprehensive effects of raloxifene hydrochloride on retinal, choroidal and retrobulbar hemodynamics and on visual function in post-menopausal women. Design: Twenty-four post-menopausal women (age 55 ± 3.8 years) were recruited for this cross-sectional study: 12 received placebo and 12 received raloxifene hydrochloride 60 mg once a day for 3 months. Baseline measurements of both groups included heart rate (HR), blood pressure (BP), visual acuity, contrast sensitivity and intraocular pressure (IOP) for both eyes. A comprehensive ocular blood flow (OBF) assessment was obtained for each patient in a randomly chosen study eye. Retinal blood flow data was obtained using confocal scanning laser Doppler flowmetry [Heidelberg Retinal Flowmeter (HRF)]. Color Doppler imaging (CDI) was used to assess retrobulbar hemodynamics in the ophthalmic, central retinal, short nasal and temporal posterior ciliary arteries. Baseline vision and hemodynamics in post-menopausal subjects were compared using paired Student's t tests, and the percentage change in baseline versus 3-month parameters was analyzed. Results: There were no statistically significant differences between 3 months of raloxifene therapy and placebo in terms of age, HR, arterial or mean BP, visual acuity, contrast sensitivity, IOP or retinal or retrobulbar blood flow. Conclusion: Raloxifene therapy at 60 mg/day had no clinically significant impact on BP, IOP or OBF in post-menopausal women.",
keywords = "Blood flow, Hormone, Raloxifene, Vision",
author = "Brent Siesky and Akon Harris and Nisha Kheradiya and Rita Ehrlich and Carissa Klaas and Boaris Kaplan and Yara Catoira and Lynne McCranor and Carlos Rospigliosi and Mira Harris",
year = "2009",
month = "1",
day = "1",
doi = "10.1007/s10792-008-9224-4",
language = "English (US)",
volume = "29",
pages = "225--230",
journal = "International Ophthalmology",
issn = "0165-5701",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - The effects of raloxifene hydrochloride on ocular hemodynamics and visual function

AU - Siesky, Brent

AU - Harris, Alon

AU - Kheradiya, Nisha

AU - Ehrlich, Rita

AU - Klaas, Carissa

AU - Kaplan, Boaris

AU - Catoira-Boyle, Yara

AU - McCranor, Lynne

AU - Rospigliosi, Carlos

AU - Harris, Mira

PY - 2009

Y1 - 2009

N2 - Objective: To assess the comprehensive effects of raloxifene hydrochloride on retinal, choroidal and retrobulbar hemodynamics and on visual function in post-menopausal women. Design: Twenty-four post-menopausal women (age 55 ± 3.8 years) were recruited for this cross-sectional study: 12 received placebo and 12 received raloxifene hydrochloride 60 mg once a day for 3 months. Baseline measurements of both groups included heart rate (HR), blood pressure (BP), visual acuity, contrast sensitivity and intraocular pressure (IOP) for both eyes. A comprehensive ocular blood flow (OBF) assessment was obtained for each patient in a randomly chosen study eye. Retinal blood flow data was obtained using confocal scanning laser Doppler flowmetry [Heidelberg Retinal Flowmeter (HRF)]. Color Doppler imaging (CDI) was used to assess retrobulbar hemodynamics in the ophthalmic, central retinal, short nasal and temporal posterior ciliary arteries. Baseline vision and hemodynamics in post-menopausal subjects were compared using paired Student's t tests, and the percentage change in baseline versus 3-month parameters was analyzed. Results: There were no statistically significant differences between 3 months of raloxifene therapy and placebo in terms of age, HR, arterial or mean BP, visual acuity, contrast sensitivity, IOP or retinal or retrobulbar blood flow. Conclusion: Raloxifene therapy at 60 mg/day had no clinically significant impact on BP, IOP or OBF in post-menopausal women.

AB - Objective: To assess the comprehensive effects of raloxifene hydrochloride on retinal, choroidal and retrobulbar hemodynamics and on visual function in post-menopausal women. Design: Twenty-four post-menopausal women (age 55 ± 3.8 years) were recruited for this cross-sectional study: 12 received placebo and 12 received raloxifene hydrochloride 60 mg once a day for 3 months. Baseline measurements of both groups included heart rate (HR), blood pressure (BP), visual acuity, contrast sensitivity and intraocular pressure (IOP) for both eyes. A comprehensive ocular blood flow (OBF) assessment was obtained for each patient in a randomly chosen study eye. Retinal blood flow data was obtained using confocal scanning laser Doppler flowmetry [Heidelberg Retinal Flowmeter (HRF)]. Color Doppler imaging (CDI) was used to assess retrobulbar hemodynamics in the ophthalmic, central retinal, short nasal and temporal posterior ciliary arteries. Baseline vision and hemodynamics in post-menopausal subjects were compared using paired Student's t tests, and the percentage change in baseline versus 3-month parameters was analyzed. Results: There were no statistically significant differences between 3 months of raloxifene therapy and placebo in terms of age, HR, arterial or mean BP, visual acuity, contrast sensitivity, IOP or retinal or retrobulbar blood flow. Conclusion: Raloxifene therapy at 60 mg/day had no clinically significant impact on BP, IOP or OBF in post-menopausal women.

KW - Blood flow

KW - Hormone

KW - Raloxifene

KW - Vision

UR - http://www.scopus.com/inward/record.url?scp=68249146659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249146659&partnerID=8YFLogxK

U2 - 10.1007/s10792-008-9224-4

DO - 10.1007/s10792-008-9224-4

M3 - Article

C2 - 18427730

AN - SCOPUS:68249146659

VL - 29

SP - 225

EP - 230

JO - International Ophthalmology

JF - International Ophthalmology

SN - 0165-5701

IS - 4

ER -